Peter Heseltine

picture of Peter  Heseltine

Professor of Clinical Medicine, Infectious Diseases
School of Medicine


MB BCh BAO, Trinity College, Dublin University, 1971
M.A., Trinity College, Dublin University, 1969, English Literature

Phone: (714) 456-7612
Email: peter.heseltine@uci.edu

University of California, Irvine

Irvine, CA 92697
Research Interests
infection related neurologic disorders, diagnostic biomarkers, HIV, nosocomial infections
Academic Distinctions
Fellow, American Association for Clinical Chemistry
Fellow, Infectious Disease Society of America
Fellow, Society for Healthcare Epidemiology of America
Fellow, American College of Physicians
Appointments
Chief Medical Officer, Singulex, Inc. 2014-2016
Senior Vice President, Chief Medical Officer, Prometheus Laboratories, 2011-2013
Vice President, Corporate Medical Director, Beckman Coulter, 2005-2011
Medical Director Infectious Diseases, Nichols Institute Quest Diagnostics, 2000–2005
Professor of Medicine, University of Southern California, 1990-2001
Chief Physician and Hospital Epidemiologist, LAC-USC Medical Center, 1977–2000
Publications
Paganini-Hill A, Lozano E, Fischberg M., Perez-Barreto MP, Rajamani K, Ameriso SF, Heseltine PNR and M. Fisher: Infection and risk of ischemic stroke: differences among stroke subtypes. Stroke. 2003 Feb;34(2):452-7
 
Marjot J, Liebetrau C, Goodson RJ, Kaier T, Weber E, Heseltine P, Marber MS The development and application of a high-sensitivity immunoassay for cardiac myosin-binding protein C. Transl Res. 2016 Apr;170:17-25.e1-5
 
Boos CJ, Woods DR, Varias A, Sheryl Biscocho S, Heseltine P, Mellor AJ. High altitude and acute mountain sickness and changes in circulating endothelin-1, interleukin-6 and interleukin-17a. High Altitude Medicine & Biology High Alt Med Biol. 2016 Mar:17:25-31
 
Vitiello B, Goodkin K, Ashtana D, Shapshak P, Atkinson JH, Heseltine PN, Eaton E, Heaton R, Lyman WD. HIV-1 RNA concentration and cognitive performance in a cohort of HIV positive people. AIDS. 2007 Jul 11;21(11):1415-22.
 
Goodkin K, Vitiello B, Lyman WD, Asthana D, Atkinson JH, Heseltine PN, Molina R, Zheng W, Khamis I, Wilkie FL, Shapshak P: Cerebrospinal and peripheral human immunodeficiency virus load in a multi-site, randomized, double-blind, placebo controlled trial of D-Ala-Peptide T-amide in HIV-1 associated cognitive-motor impairment. J Neurovirol. 2006 Jun;12(3):178-89
Grants
Principal Investigator (USC): California NeuroAIDS Tissue Network (CNTN). University of California San Diego and the National Institute of Mental Health. MH-98-009. 1998 - 2003
Principal investigator: Phase II study of the efficacy of Peptide T in HIV-positive individuals with cognitive impairment. National Institute of Mental Health. NIMH-OD-90-0013
Co-investigator: Mechanisms of Ischaemic Stroke: Stroke and Infectious/Inflammatory Disorders. National Institute of Stroke 1994 - 1999
Professional Societies
Infectious Diseases Society of America
Society for Healthcare Epidemiology of America
American Society for Microbiology
American Association for Clinical Chemistry
American College of Physicians
Other Experience
Chairman, Data Safety Monitoring Board
National Institute on Drug Abuse, Division of Pharmacotherapies and Medical Consequence of Drug Abuse 1994—Pres

Voting Member, Medicare Evidence Development & Coverage Advisory Committee
Centers for Medicare & Medicaid Services 2010—2013

Member, Document Development Committees
Clinical Laboratories Standards Institute 2011—2015

Member UCOP Systemwide COVID Planning Group
University of California 2020—curr

Graduate Programs
Infectious Disease (IM)

Internal Medicine

Last updated
09/22/2021